Missouri - San Francisco Bay Area - Clayton | Canada
| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Industries | BioTech • AgroTech • FinTech (& Financials services) • Energy • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Advertising • Impact • Material Science • Medical Devices (& Hospital Services) • DeepTech • Healthcare (& Wellness) • Life Science • Pharmaceutical (& Medicine) • Woman Focused • Diagnostics |
| Stages | Seed, Series A, Early Stage, Series B, Grant, Pre-seed |
| Investing | United States • Canada |
| Investment Range | $100,000 - $22,400,000 |
| Investment Sweet Spot | $1,500,000 |
What is Breakout Ventures?
Breakout Ventures is a San Francisco-based venture capital firm that specializes in funding early-stage companies within a range of technology-driven sectors.
Founded in 2016, their investment focus encompasses Biotech, AgroTech, FinTech and Financial Services, Energy, CleanTech, Artificial Intelligence and Big Data, HealthTech and Fitness, Impact, Material Science, Medical Devices and Hospital Services, DeepTech, Healthcare and Wellness, Pharmaceutical and Medicine, and initiatives focused on Women.
They seek to partner with companies that are creating new biology applications for human health such as therapeutics, diagnostics, and devices, as well as sustainable and synthetic biology solutions for industrial applications. Breakout Ventures provides Seed and Series A funding, with investments typically ranging from $500,000 to $5,000,000, aiming for a 'sweet spot' of around $3,000,000.
On their website, Breakout Ventures emphasizes their role in championing intelligent biosciences, supporting the convergence of biology, chemistry, and technology to forge novel science frontiers. They underscore their commitment to entrepreneurs in achieving significant milestones to foster value creation and realization of vision within the bio-based sectors. Their portfolio includes companies like Cytovale, which is involved in diagnosing immune-mediated diseases, Immusoft, focused on sustained protein-producing therapeutics, Noetik in cancer immunotherapies, and Twelve for carbon transformation technology.
Breakout Ventures is dedicated to building a vibrant community of innovative thinkers and offers an expansive network to illuminate pathways to success, recognizing the importance of diverse perspectives in advancing transformative ideas.
What they say:
We invest in creative biosciences - companies building new biology for applications in human health (therapeutics, diagnostics, and devices) and industry (sustainability and synthetic biology). We invest in Seed and Series A companies.
Breakout Ventures's investments on record
What are the investment firms similar to Breakout Ventures
Pique Ventures
OMERS Ventures
Golden Ventures
Green Century Investment
Covington Capital Corporation
Celtic House Venture Partners
Banyan Capital Partners
Pathbreaker Ventures
BNOTIONS
Stack Capital
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 71-75 Shelton Street, Covent Garden, WC2H 9JQ
- London, U.K.
- contact@angelspartners.com
